Vrna stock alert: halper sadeh llc is investigating whether the sale of verona pharma plc is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of verona pharma plc (nasdaq: vrna) to merck for $107.00 per american depository share is fair to verona shareholders. halper sadeh encourages verona shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. the investigation concerns whether verona and its.
VRNA Ratings Summary
VRNA Quant Ranking